Ethambutol


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1544 CYP1A2 Decreases activity PMID:24910189
1557 CYP2C19 Decreases activity PMID:24910189
1565 CYP2D6 Decreases activity PMID:24910189
1571 CYP2E1 Affects activity PMID:24910189; PMID:27334974
1571 CYP2E1 Increases expression PMID:27334974
23657 SLC7A11 Increases expression PMID:32816093
3552 IL1A Increases expression PMID:32816093
3553 IL1B Decreases expression PMID:25051504
3569 IL6 Decreases expression PMID:25051504
3576 CXCL8 Increases expression PMID:32816093
3586 IL10 Decreases expression PMID:25051504
3920 LAMP2 Increases expression PMID:19063910
3952 LEP Decreases expression PMID:25051504
4233 MET Increases expression PMID:32816093
55022 PID1 Increases expression PMID:32816093
59272 ACE2 Increases expression PMID:32808185
6347 CCL2 Affects expression PMID:25051504
6352 CCL5 Affects expression PMID:25051504
654 BMP6 Decreases expression PMID:32816093
6590 SLPI Increases expression PMID:32816093
7113 TMPRSS2 Increases expression PMID:32808185

DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.